Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward.

Saved in:
Bibliographic Details
Title: Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward.
Authors: Bilé-Silva A; Urology Department, Egas Moniz Hospital, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal., Lopez-Beltran A; Department of Morphological Sciences, Unit of Pathology, Cordoba University Medical School, Cordoba, Spain., Blanca A; Urology Department, Reina Sofia University Hospital, Cordoba, Spain., Lopez-Rios F; Pathology Department, 12 de Octubre University Hospital, Universidad Complutense de Madrid. Research Institute 12 de Octubre University Hospital (i+12), Madrid, Spain., Gómez-Gómez E; Urology Department, Reina Sofia University Hospital, Cordoba, Spain., Cimadamore A; Institute of Pathological Anatomy, Department of Medical Area (DAME), University of Udine, Udine, Italy., Montironi R; Molecular Medicine and Cell Therapy Foundation, Polytechnic University of Marche, Ancona, Italy., Vau N; Medical Oncology, Champalimaud Clinical Center, Lisbon, Portugal., Cheng L; Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Providence, RI, USA.
Source: Expert opinion on biological therapy [Expert Opin Biol Ther] 2023 May; Vol. 23 (5), pp. 407-418. Date of Electronic Publication: 2023 Apr 10.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1744-7682
DOI:10.1080/14712598.2023.2201371